Question (58905) | Kainic acid, prototypic kainate receptor agonist (ab120100)

Go to datasheet (ab120100)


I am wondering if your supplier or manufacturing process of kainate has changed since Ascent was purchased by abcam. We are finding that we require much higher dosing to get seizures in mouse pups.

Thanks. When I tried to ask this question from your technical support page, it didn't recognize the product #. Frustrating!!


Thank you very much for contacting us and letting us know about the trouble with ab120100.

I am very sorry for the variability that you've experienced. The chemistshave assured me thatnothing has changed for the production of this product, so we would expect it to perform comparably to previous batches. The current lot hasgreater than 99% purity, whichisthe same asall previous batches.

We do have different lots in stock, if you would be interested in trying a different one free of charge. If you would like to accept this, please send me:1) Your Abcam order or PO number
2) A description of your protocol using ab120100
3) Lot numbers of the previously vials you have used (if available)

I also apologize for the difficulty submitting an inquiry directly from the website. Most of our productsystems require an "ab" before the product code, so typing in "120100" won't be recognized, only "ab120100" will. Please let me know if this is not the source of the problem, and I'll contact our IT team to investigate it.

I hope that this information will be useful, but if you have any questions or if there is anything else that we can do for you, please don't hesitate to ask.

Sign up